Urinary pentosidine improves risk classification using fracture risk assessment tools for postmenopausal women
Authors:
Open Access
- 19 July 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 26 (11) , 2778-2784
Abstract
We investigated whether measurement of pentosidine, in addition to the conventional risk assessment tool, the Fracture and Immobilization Score (FRISC), improves early identification of fracture cases. A total of 765 postmenopausal Japanese women with baseline measurement of urinary pentosidine were followed in a hospital‐based cohort study. Endpoints were incidence of vertebral fracture, incidence of long bone fracture, and incidence of long bone and vertebral fracture. To assess the effect of pentosidine on fracture risk, we fitted multivariate Cox regression models adjusted for age, body weight, diabetes mellitus, lumbar BMD, prior fracture, and presence of back pain. To explore potential nonlinear relationships, we fitted a multivariate generalized additive model. To assess the discriminatory power of pentosidine, we performed receiver operating characteristic analysis. The hazard ratios for a 1 SD increase in pentosidine were 1.18 (95% CI 1.05–1.33, p < 0.01) for vertebral fracture and 1.20 (95% CI 1.07–1.33, p < 0.01) for long bone and vertebral fractures. The relationship was approximately linear, and there was no indication of the presence of a threshold. The C statistics were 0.732 (95% CI 0.686–0.778) for the model with both pentosidine and the 10‐year risk and 0.702 (95% CI 0.654–0.750) for the 10‐year risk alone. Eighty‐three subjects (11%) in the whole cohort were in the highest quartile of pentosidine, although their 10‐year risks were less than 15% and included 17 incident vertebral fracture cases. Urinary pentosidine improves risk classification using conventional risk assessment tools. Optimal clinical strategies of diagnosis and treatment remain uncertain and in need of additional investigation. © 2011 American Society for Bone and Mineral ResearchKeywords
This publication has 25 references indexed in Scilit:
- The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women―A joint analysis of the Nagano, Miyama, and Taiji CohortsBone, 2010
- Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitusOsteoporosis International, 2009
- Population screening for osteoporosis risk: a randomised control trial of medication use and fracture riskOsteoporosis International, 2009
- Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)Osteoporosis International, 2008
- Bone Quality — The Material and Structural Basis of Bone Strength and FragilityNew England Journal of Medicine, 2006
- Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical boneBone, 2006
- Assessment of fracture riskOsteoporosis International, 2004
- Relationship Between Changes in Biochemical Markers of Bone Turnover and BMD to Predict Vertebral Fracture RiskJournal of Bone and Mineral Research, 2004
- Age-related changes in the collagen network and toughness of boneBone, 2002
- Osteoporosis Prevention, Diagnosis, and TherapyJAMA, 2001